WallStreetZenWallStreetZen

NASDAQ: TTRX
Turn Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TTRX

Based on 2 analysts offering 12 month price targets for Turn Therapeutics Inc

Min Forecast
$10.00-6.89%
Avg Forecast
$17.00+58.29%
Max Forecast
$24.00+123.46%

Should I buy or sell TTRX stock?

Based on 2 analysts offering ratings for Turn Therapeutics Inc.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
1 analysts 50%
Strong Sell
0 analysts 0%
Although TTRX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates TTRX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their TTRX stock forecasts and price targets.

TTRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-24
lockedlocked$00.00+00.00%2026-09-14

1 of 1

Forecast return on equity

Is TTRX forecast to generate an efficient return?

Company
-796.21%
Industry
24.45%
Market
177.65%
TTRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TTRX forecast to generate an efficient return on assets?

Company
-32.25%
Industry
23.74%
TTRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TTRX earnings per share forecast

What is TTRX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.47
Avg 2 year Forecast
-$0.43
Avg 3 year Forecast
-$0.53

TTRX revenue forecast

What is TTRX's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$306.0k
Avg 2 year Forecast
$3.4M
Avg 3 year Forecast
$6.1M

TTRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TTRX$10.57$17.00+60.83%Buy
IRD$3.84$12.63+228.78%Strong Buy
ENTA$11.10$20.00+80.18%Buy
OBIO$5.45$10.67+95.72%Strong Buy
RLMD$3.10$12.00+287.10%Buy
View Top Biotech Stocks

Turn Therapeutics Stock Forecast FAQ

Is Turn Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TTRX) stock is to Buy TTRX stock.

Out of 2 analysts, 1 (50%) are recommending TTRX as a Strong Buy, 0 (0%) are recommending TTRX as a Buy, 0 (0%) are recommending TTRX as a Hold, 1 (50%) are recommending TTRX as a Sell, and 0 (0%) are recommending TTRX as a Strong Sell.

If you're new to stock investing, here's how to buy Turn Therapeutics stock.

What is TTRX's earnings growth forecast for 2026-2028?

(NASDAQ: TTRX) Turn Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.78%.

Turn Therapeutics's earnings in 2026 is -$8,445,820.On average, 4 Wall Street analysts forecast TTRX's earnings for 2026 to be -$13,976,548, with the lowest TTRX earnings forecast at -$15,179,985, and the highest TTRX earnings forecast at -$12,510,977. On average, 5 Wall Street analysts forecast TTRX's earnings for 2027 to be -$12,761,196, with the lowest TTRX earnings forecast at -$14,888,062, and the highest TTRX earnings forecast at -$11,259,879.

In 2028, TTRX is forecast to generate -$15,647,657 in earnings, with the lowest earnings forecast at -$16,639,599 and the highest earnings forecast at -$14,387,623.

What is TTRX's revenue growth forecast for 2026-2028?

(NASDAQ: TTRX) Turn Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.

Turn Therapeutics's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast TTRX's revenue for 2026 to be $9,115,140, with the lowest TTRX revenue forecast at $0, and the highest TTRX revenue forecast at $15,638,721. On average, 5 Wall Street analysts forecast TTRX's revenue for 2027 to be $102,292,129, with the lowest TTRX revenue forecast at $0, and the highest TTRX revenue forecast at $159,514,954.

In 2028, TTRX is forecast to generate $182,302,805 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $375,329,304.

What is TTRX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TTRX) forecast ROA is -32.25%, which is lower than the forecast US Biotechnology industry average of 23.99%.

What is TTRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TTRX price target, the average TTRX price target is $17.00, with the highest TTRX stock price forecast at $24.00 and the lowest TTRX stock price forecast at $10.00.

On average, Wall Street analysts predict that Turn Therapeutics's share price could reach $17.00 by Sep 24, 2027. The average Turn Therapeutics stock price prediction forecasts a potential upside of 60.83% from the current TTRX share price of $10.57.

What is TTRX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TTRX) Turn Therapeutics's current Earnings Per Share (EPS) is -$0.29. On average, analysts forecast that TTRX's EPS will be -$0.47 for 2026, with the lowest EPS forecast at -$0.51, and the highest EPS forecast at -$0.42. On average, analysts forecast that TTRX's EPS will be -$0.43 for 2027, with the lowest EPS forecast at -$0.50, and the highest EPS forecast at -$0.38. In 2028, TTRX's EPS is forecast to hit -$0.53 (min: -$0.56, max: -$0.48).

What is TTRX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TTRX) forecast ROE is -796.21%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.